These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26280981)
1. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Kuhnert G; Boellaard R; Sterzer S; Kahraman D; Scheffler M; Wolf J; Dietlein M; Drzezga A; Kobe C Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):249-258. PubMed ID: 26280981 [TBL] [Abstract][Full Text] [Related]
2. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma. Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302 [TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? Voltin CA; Mettler J; Boellaard R; Kuhnert G; Dietlein M; Borchmann P; Drzezga A; Kobe C Nucl Med Commun; 2019 Mar; 40(3):249-257. PubMed ID: 30461699 [TBL] [Abstract][Full Text] [Related]
4. Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods. Brendle C; Kupferschläger J; Nikolaou K; la Fougère C; Gatidis S; Pfannenberg C Eur J Radiol; 2015 Jan; 84(1):158-162. PubMed ID: 25467224 [TBL] [Abstract][Full Text] [Related]
5. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780 [TBL] [Abstract][Full Text] [Related]
6. PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume. Knaup H; Weindler J; van Heek L; Voltin CA; Fuchs M; Borchmann P; Dietlein M; Kobe C; Roth K Acad Radiol; 2024 Jul; 31(7):3020-3025. PubMed ID: 38155023 [TBL] [Abstract][Full Text] [Related]
7. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms. Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217 [TBL] [Abstract][Full Text] [Related]
8. Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors. Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM Nucl Med Commun; 2016 Mar; 37(3):288-96. PubMed ID: 26650959 [TBL] [Abstract][Full Text] [Related]
9. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients. Lasnon C; Desmonts C; Quak E; Gervais R; Do P; Dubos-Arvis C; Aide N Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):985-96. PubMed ID: 23564036 [TBL] [Abstract][Full Text] [Related]
10. Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312 [TBL] [Abstract][Full Text] [Related]
11. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction. Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791 [TBL] [Abstract][Full Text] [Related]
12. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer. Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197 [TBL] [Abstract][Full Text] [Related]
13. Treatment response assessment in [ Dolci C; Spadavecchia C; Crivellaro C; De Ponti E; Todde S; Morzenti S; Turolla EA; Crespi A; Guerra L; Landoni C Phys Med; 2019 Jan; 57():177-182. PubMed ID: 30738523 [TBL] [Abstract][Full Text] [Related]
14. Test-Retest Variability in Lesion SUV and Lesion SUR in Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598 [TBL] [Abstract][Full Text] [Related]
15. Does PET SUV Harmonization Affect PERCIST Response Classification? Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930 [TBL] [Abstract][Full Text] [Related]
16. Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size. Otani T; Hosono M; Kanagaki M; Onishi Y; Matsubara N; Kawabata K; Kimura H AJR Am J Roentgenol; 2019 Aug; 213(2):W50-W56. PubMed ID: 30995096 [No Abstract] [Full Text] [Related]